{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:09:01Z","timestamp":1786662541393,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lungcan.2024.108023","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:02:10Z","timestamp":1731704530000},"page":"108023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6503-4418","authenticated-orcid":false,"given":"Soravis","family":"Osataphan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4205-8417","authenticated-orcid":false,"given":"Muhammad","family":"Awidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jen","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Gunturu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram","family":"Sundararaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollis","family":"Viray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-4312","authenticated-orcid":false,"given":"Edward","family":"Frankenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-2279","authenticated-orcid":false,"given":"Melissa","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"O\u2019Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Piper-Vallillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-7957","authenticated-orcid":false,"given":"Katherine","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kolnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Ghazalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Elizabeth","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-395X","authenticated-orcid":false,"given":"Daniel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-5103","authenticated-orcid":false,"given":"Prudence","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Rangachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.lungcan.2024.108023_b0005","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2024.108023_b0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non\u2013small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2024.108023_b0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer."},{"issue":"7","key":"10.1016\/j.lungcan.2024.108023_b0020","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.lungcan.2024.108023_b0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2024.108023_b0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","article-title":"Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer","volume":"6","author":"Kichenadasse","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2024.108023_b0035","doi-asserted-by":"crossref","unstructured":"D. Makrakis, K. Rounis, A.P. Tsigkas, et al. Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors. Bauckneht M, ed. PLOS ONE. 2023;18(2):e0277708. doi:10.1371\/journal.pone.0277708.","DOI":"10.1371\/journal.pone.0277708"},{"key":"10.1016\/j.lungcan.2024.108023_b0040","article-title":"Obesity, and mortality from cancer in a prospectively studied cohort of U.S Adults","author":"Overweight","year":"2003","journal-title":"N Engl J Med. Published Online"},{"issue":"6","key":"10.1016\/j.lungcan.2024.108023_b0045","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00262-022-03363-6","article-title":"Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study","volume":"72","author":"Chiang","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.lungcan.2024.108023_b0050","doi-asserted-by":"crossref","first-page":"e005719","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer."},{"issue":"9","key":"10.1016\/j.lungcan.2024.108023_b0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000516671","article-title":"The relationship of diabetes mellitus to efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer","volume":"99","author":"Jacobi","year":"2021","journal-title":"Oncology."},{"issue":"14","key":"10.1016\/j.lungcan.2024.108023_b0060","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2024.108023_b0065","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bl\u00fcher","year":"2020","journal-title":"Endocr. Rev."},{"issue":"17","key":"10.1016\/j.lungcan.2024.108023_b0070","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: american society of clinical oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.108023_b0075","doi-asserted-by":"crossref","first-page":"e2037120","DOI":"10.1001\/jamanetworkopen.2020.37120","article-title":"Association of performance status with survival in patients with advanced non\u2013small cell lung cancer treated with pembrolizumab monotherapy","volume":"4","author":"Sehgal","year":"2021","journal-title":"JAMA Netw. Open."},{"issue":"3","key":"10.1016\/j.lungcan.2024.108023_b0080","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.cllc.2020.05.028","article-title":"Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non\u2013small-cell lung cancer","volume":"22","author":"Sehgal","year":"2021","journal-title":"Clin. Lung Cancer."},{"issue":"5","key":"10.1016\/j.lungcan.2024.108023_b0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/EDE.0000000000001630","article-title":"Visualizing the (causal) effect of a continuous variable on a time-to-event outcome","volume":"34","author":"Denz","year":"2023","journal-title":"Epidemiology."},{"issue":"7","key":"10.1016\/j.lungcan.2024.108023_b0090","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-015-3599-3","article-title":"The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review","volume":"58","author":"English","year":"2015","journal-title":"Diabetologia."},{"issue":"5","key":"10.1016\/j.lungcan.2024.108023_b0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4093\/dmj.2013.37.5.343","article-title":"Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects","volume":"37","author":"Son","year":"2013","journal-title":"Diabetes Metab. J."},{"issue":"3","key":"10.1016\/j.lungcan.2024.108023_b0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/clinem\/dgac587","article-title":"Glycemic gap predicts mortality in a large multicenter cohort hospitalized with COVID-19","volume":"108","author":"McDonnell","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lungcan.2024.108023_b0105","unstructured":"G.E. Umpierrez, S.D. Isaacs, N. Bazargan, X. You, L.M. Thaler, A.E. Kitabchi. Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes."},{"issue":"9206","key":"10.1016\/j.lungcan.2024.108023_b0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(99)08415-9","article-title":"Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview","volume":"355","author":"Capes","year":"2000","journal-title":"Lancet."},{"issue":"7851","key":"10.1016\/j.lungcan.2024.108023_b0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","article-title":"CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours","volume":"591","author":"Zappasodi","year":"2021","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.lungcan.2024.108023_b0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell."},{"issue":"615","key":"10.1016\/j.lungcan.2024.108023_b0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba6006","article-title":"Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice","volume":"13","author":"Kalia","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.108023_b0130","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lungcan.2024.108023_b0135","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1038\/s41598-023-33049-7","article-title":"Anti-tumor effects of anti-programmed cell death-1 antibody treatment are attenuated in streptozotocin-induced diabetic mice","volume":"13","author":"Ito","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lungcan.2024.108023_b0140","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.2147\/CMAR.S304022","article-title":"Baseline serum cholesterol levels predict the response of patients with advanced non-small cell lung cancer to immune checkpoint inhibitor-based treatment","volume":"13","author":"Tong","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.108023_b0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00262-021-02979-4","article-title":"Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer","volume":"71","author":"Karayama","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lungcan.2024.108023_b0150","doi-asserted-by":"crossref","unstructured":"F. Pecci, L. Cantini, V. Cognigni, et al. Prognostic impact of blood lipid profile in patients with advanced solid tumors treated with immune checkpoint inhibitors: a multicenter cohort study. The Oncologist. Published online October 5, 2023:oyad273. doi:10.1093\/oncolo\/oyad273.","DOI":"10.1093\/oncolo\/oyad273"},{"issue":"6","key":"10.1016\/j.lungcan.2024.108023_b0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/CJI.0000000000000321","article-title":"The prognostic role of high blood cholesterol in advanced cancer patients treated with immune checkpoint inhibitors","volume":"43","author":"Perrone","year":"2020","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.lungcan.2024.108023_b0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.lungcan.2024.108023_b0165","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","article-title":"High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice","volume":"158","author":"Qin","year":"2020","journal-title":"Gastroenterology."},{"issue":"7","key":"10.1016\/j.lungcan.2024.108023_b0170","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell."},{"issue":"7839","key":"10.1016\/j.lungcan.2024.108023_b0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.lungcan.2024.108023_b0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.10.031","article-title":"High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients","volume":"144","author":"Cantini","year":"2021","journal-title":"Eur. J. Cancer."},{"issue":"13","key":"10.1016\/j.lungcan.2024.108023_b0185","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/1759-7714.14001","article-title":"Impact of concomitant medication on clinical outcomes in patients with advanced non\u2010small cell lung cancer treated with immune checkpoint inhibitors: a retrospective study","volume":"12","author":"Miura","year":"2021","journal-title":"Thorac Cancer."},{"issue":"4","key":"10.1016\/j.lungcan.2024.108023_b0190","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.lungcan.2024.108023_b0195","doi-asserted-by":"crossref","first-page":"e002614","DOI":"10.1136\/jitc-2021-002614","article-title":"Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy","volume":"9","author":"Munoz","year":"2021","journal-title":"J. Immunother. Cancer."},{"issue":"3","key":"10.1016\/j.lungcan.2024.108023_b0200","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2017-02085","article-title":"Relationship between 12 adipocytokines and distinct components of the metabolic syndrome","volume":"103","author":"Ebert","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lungcan.2024.108023_b0205","article-title":"Adiponectin deficiency enhances anti-tumor immunity of CD8+ T cells in rhabdomyosarcoma through inhibiting STAT3 activation","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.108023_b0210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2337\/db15-1696","article-title":"Antigen presentation and T-cell activation are critical for RBP4-induced insulin resistance","volume":"65","author":"Moraes-Vieira","year":"2016","journal-title":"Diabetes."},{"issue":"31","key":"10.1016\/j.lungcan.2024.108023_b0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021254","article-title":"Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: a case-control study","volume":"99","author":"Hu","year":"2020","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.lungcan.2024.108023_b0220","doi-asserted-by":"crossref","unstructured":"Q.C. Yang, S. Wang, Y.T. Liu, et al. Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer. iScience. 2023;26(6):106916. doi:10.1016\/j.isci.2023.106916.","DOI":"10.1016\/j.isci.2023.106916"},{"issue":"24","key":"10.1016\/j.lungcan.2024.108023_b0225","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224005579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224005579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T02:22:52Z","timestamp":1733278972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S0169500224005579"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.108023","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.108023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108023"}}